Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_assertion type Assertion NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_head.
- NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_assertion description "[The aim of our study was to evaluate the effect of KIR genes and KIR ligands on leukemia free survival (LFS) and relapse rate in a well-defined, homogeneous group of CML patients phase upon HLA identical sibling SCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_provenance.
- NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_assertion evidence source_evidence_literature NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_provenance.
- NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_assertion SIO_000772 18555529 NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_provenance.
- NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_assertion wasDerivedFrom befree-20140225 NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_provenance.
- NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_assertion wasGeneratedBy ECO_0000203 NP338066.RAxCT9TzrhdYAnrH8vT11w5xTcW1aPLZC7Xhgq-j56hZg130_provenance.